Nalmefene (Titan Pharmaceuticals/Opiant Pharmaceuticals)

N/A

Report date: 2025/12/31 17:07:10

Base Information

Drug NameNalmefene (Titan Pharmaceuticals/Opiant Pharmaceuticals)
Drug Alias NamenalmefeneOpioid antagonist (Titan Pharmaceuticals/Opiant Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor inverse agonists
TargetsMu opioid receptor
Therapy Area/IndicationsOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTitan Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTitan Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A